Virtu Financial LLC Neogenomics Inc Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$9.09 - $19.45 $158,202 - $338,507	17,404 New	17,404 $303,000
Q2 2022 Aug 09, 2022	SELL	$7.06 - $13.97 $261,227 - $516,903	-37,001 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$12.15 - $35.28 $349,336 - $1.01 Million	28,752 Added 348.55%	37,001 $450,000
Q4 2021 Feb 17, 2022	BUY	$30.49 - $48.49 $251,512 - $399,994	8,249 New	8,249 $281,000
Q4 2019 Feb 04, 2020	SELL	$18.96 - $29.84 $289,784 - $456,074	-15,284 Closed	0 $0
Q3 2019 Nov 20, 2019	BUY	$19.12 - $26.24 $54,281 - $74,495	2,839 Added 22.81%	15,284 $292,000
Q2 2019 Aug 13, 2019	BUY	$19.57 - $24.1 $243,548 - $299,924	12,445 New	12,445 $273,000

295

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.16B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.